Notice: Function amp_is_available was called incorrectly. `amp_is_available()` (or `amp_is_request()`, formerly `is_amp_endpoint()`) was called too early and so it will not work properly. WordPress is currently doing the `amp_init` hook. Calling this function before the `wp` action means it will not have access to `WP_Query` and the queried object to determine if it is an AMP response, thus neither the `amp_skip_post()` filter nor the AMP enabled toggle will be considered. It appears the plugin with slug `schema-and-structured-data-for-wp` is responsible; please contact the author. Please see Debugging in WordPress for more information. (This message was added in version 2.0.0.) in /home/u885321871/domains/fintechinshorts.com/public_html/wp-includes/functions.php on line 6114

Notice: Function amp_is_available was called incorrectly. `amp_is_available()` (or `amp_is_request()`, formerly `is_amp_endpoint()`) was called too early and so it will not work properly. WordPress is currently doing the `amp_init` hook. Calling this function before the `wp` action means it will not have access to `WP_Query` and the queried object to determine if it is an AMP response, thus neither the `amp_skip_post()` filter nor the AMP enabled toggle will be considered. It appears the plugin with slug `schema-and-structured-data-for-wp` is responsible; please contact the author. Please see Debugging in WordPress for more information. (This message was added in version 2.0.0.) in /home/u885321871/domains/fintechinshorts.com/public_html/wp-includes/functions.php on line 6114

Notice: Function amp_is_available was called incorrectly. `amp_is_available()` (or `amp_is_request()`, formerly `is_amp_endpoint()`) was called too early and so it will not work properly. WordPress is currently doing the `init` hook. Calling this function before the `wp` action means it will not have access to `WP_Query` and the queried object to determine if it is an AMP response, thus neither the `amp_skip_post()` filter nor the AMP enabled toggle will be considered. It appears the plugin with slug `schema-and-structured-data-for-wp` is responsible; please contact the author. Please see Debugging in WordPress for more information. (This message was added in version 2.0.0.) in /home/u885321871/domains/fintechinshorts.com/public_html/wp-includes/functions.php on line 6114

Notice: Function amp_is_available was called incorrectly. `amp_is_available()` (or `amp_is_request()`, formerly `is_amp_endpoint()`) was called too early and so it will not work properly. WordPress is currently doing the `init` hook. Calling this function before the `wp` action means it will not have access to `WP_Query` and the queried object to determine if it is an AMP response, thus neither the `amp_skip_post()` filter nor the AMP enabled toggle will be considered. It appears the plugin with slug `schema-and-structured-data-for-wp` is responsible; please contact the author. Please see Debugging in WordPress for more information. (This message was added in version 2.0.0.) in /home/u885321871/domains/fintechinshorts.com/public_html/wp-includes/functions.php on line 6114
Antisense Therapeutics: Starts dosing monkeys in ATL1102 toxicology study | Fintech InShorts: Latest fintech news, analysis by experts

Less than 1 min.Read

Antisense Therapeutics: Starts dosing monkeys in ATL1102 toxicology study

By Steve Sam

March 8, 2023

Antisense Therapeutics Starts dosing monkeys in ATL1102 toxicology study

Antisense Therapeutics (ANP) commences the dosing stage of a nine-month chronic monkey toxicology study of its ATL1102 treatment in the US
The toxicology study is expected to support the advancement of ATL1102 for the potential treatment of Duchenne muscular dystrophy (DMD)
Antisense says the completion of the toxicology study should be the final requisite step for the US FDA to allow dosing of the product for a term longer than six months
The study should complete animal dosing by November this year, with results to be released in the first half of 2024
ANP shares are down 4.26 per cent and trading at nine cents at 12:23 pm AEDT

Tags
Antisense Therapeutics

Hot this week

Topics

Popular Categories

FinTechBankingBusinessFundingAIPaymentsPartnership

AsiaPay: Launches Visa Instalments

Fiserv: Introduces Fraud Mitigation Solution to Simplify How Large Businesses Manage Risk

Antisense Therapeutics: Starts dosing monkeys in ATL1102 toxicology study

Antisense Therapeutics Starts dosing monkeys in ATL1102 toxicology study

Banking as a Service: Meaning, Examples, Benefits and Future

Best fintech blogs and websites

What is Fintech?

How to buy shares online

Is it worth investing in life insurance over 60?

Topics

Singapore-based fintech start-up WSPN bags $30m seed funding

Mastercard set to lay off around 3% of global workforce

HSBC reportedly considering sale of its South African business

ABN Amro goes live with CBA’s IBAS TDD software and nCino’s cloud banking platform

USAA president and CEO Wayne Peacock to retire in 2025

Singapore’s Valverde taps Broadridge for investment management solution

US fintech Amount lands $30m in fresh funding to advance AI capabilities

Sharon Naidoo named new TransUnion CFO for the UK and Europe

Related Articles

Singapore-based fintech start-up WSPN bags $30m seed funding

Mastercard set to lay off around 3% of global workforce

HSBC reportedly considering sale of its South African business

ABN Amro goes live with CBA’s IBAS TDD software and nCino’s cloud banking platform

USAA president and CEO Wayne Peacock to retire in 2025

Company

Headlines

Singapore-based fintech start-up WSPN bags $30m seed funding

Mastercard set to lay off around 3% of global workforce

HSBC reportedly considering sale of its South African business

ABN Amro goes live with CBA’s IBAS TDD software and nCino’s cloud banking platform

Newsletter